ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,043Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 1558

$1.34M Total Retail Price of All Prescriptions

Rank: 44 out of 1558

994 Patients Receiving at Least One Drug in Part D
83% Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in North Carolina
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

10% of this provider’s 994 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 994 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 1,124 958 178 1 2
AMLODIPINE BESYLATE 830 737 142 2 1
OMEPRAZOLE 824 640 157 3 3
LISINOPRIL 716 602 120 4 5
POTASSIUM CHLORIDE 673 575 113 5 16
FUROSEMIDE 650 580 146 6 7
LEVOTHYROXINE SODIUM 641 545 103 7 4
GABAPENTIN 547 399 109 8 15
METFORMIN HCL 509 369 82 9 8
CLOPIDOGREL 495 466 70 10 19
ATORVASTATIN CALCIUM 469 401 102 11 6
HYDROCODONE-ACETAMINOPHEN 449 318 120 S3 12 9
METOPROLOL TARTRATE 447 392 83 13 11
METOPROLOL SUCCINATE 383 349 64 14 13
TRAMADOL HCL 368 270 96 15 21
LOSARTAN POTASSIUM 365 315 61 16 14
NEXIUM 339 231 56 17 27
ZOLPIDEM TARTRATE 331 240 64 18 22
WARFARIN SODIUM 325 298 61 19 18
PREDNISONE 323 250 204 20 39
SERTRALINE HCL 308 250 56 21 24
HYDROCHLOROTHIAZIDE 288 246 51 22 10
ALPRAZOLAM 287 214 73 B 23 17
ATENOLOL 281 262 47 24 20
CARVEDILOL 281 224 53 24 25
DONEPEZIL HCL 272 272 40 26 35
OXYCODONE-ACETAMINOPHEN 258 139 59 S2 27 73
AMOX TR-POTASSIUM CLAVULANATE 241 185 187 28 130
CITALOPRAM HBR 239 174 52 29 26
CRESTOR 232 166 35 30 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 227 164 39 31 32
TAMSULOSIN HCL 224 219* 36 32 34
ALENDRONATE SODIUM 222 188 43 33 42
ZETIA 214 180 34 34 64
LOSARTAN-HYDROCHLOROTHIAZIDE 203 169 32 35 36
CYMBALTA 200 95 32 36 47
SYNTHROID 173 144 37 37 29
ISOSORBIDE MONONITRATE ER 168 154 22 38 53
PIOGLITAZONE HCL 159 148 24 R 39 81
SPIRONOLACTONE 149 111 20 40 61
DIGOX 149 144* 28 40 96
ROPINIROLE HCL 149 127 27 40 99
LANTUS SOLOSTAR 147 108 27 43 68
PRAVASTATIN SODIUM 147 125 29 43 12
AMITRIPTYLINE HCL 146 109 24 R 45 78
HYDRALAZINE HCL 143 130 29 46 66
BUMETANIDE 143 102 25 46 145
MONTELUKAST SODIUM 135 95 22 48 48
FENTANYL 130 49 22 S2 49 114
VALSARTAN-HYDROCHLOROTHIAZIDE 126 121* 21 50 65
PANTOPRAZOLE SODIUM 121 107 21 51 28
ALLOPURINOL 119 95 25 52 33
CIPROFLOXACIN HCL 118 91 84 53 76
LANSOPRAZOLE 116 97 23 54 136
CYCLOBENZAPRINE HCL 112 43 35 R 55 71
COLCRYS 109 96 35 56 108
TRAZODONE HCL 109 70 22 56 46
DIOVAN 108 103* 18 58 44
CLONAZEPAM 107 49 21 B 59 41
POLYETHYLENE GLYCOL 3350 107 95 32 59 72
FINASTERIDE 106 106 19 61 88
PROAIR HFA 106 76 33 61 52
AZITHROMYCIN 102 86 79 63 59
TRIAMTERENE-HCTZ 100 95* 20 64 49
OXYCODONE HCL-ACETAMINOPHEN 97 23 16 S2 65 83
LORAZEPAM 97 79 26 B 65 31
CELEBREX 95 90* 18 67 79
VERAPAMIL ER 95 55 15 67 94
ADVAIR DISKUS 94 50 21 69 54
FENOFIBRATE* 93 73 16 70 69
ESCITALOPRAM OXALATE 93 81 17 70 51
MELOXICAM 88 37 14 72 38
AMLODIPINE BESYLATE-BENAZEPRIL 86 63 14 73 77
PREMARIN 85 71 13 R 74 126
FLUTICASONE PROPIONATE 83 59 36 75 30
GLIPIZIDE 82 63 16 76 63
LOVASTATIN 82 64 16 76 45
LYRICA 81 62 18 78 93
OXYCODONE HCL 80 25 14 S2 79 82
PAROXETINE HCL 80 75* 14 79 80
PROMETHAZINE HCL 78 25 24 R 81 95
DIAZEPAM 76 28 23 B 82 85
TEMAZEPAM 75 70* 15 B 83 98
RANITIDINE HCL 72 72 12 84 50
CILOSTAZOL 71 <11 <11 85 236
NAMENDA 70 70 15 86 43
OXYBUTYNIN CHLORIDE 70 65* 14 86 172
CEFUROXIME 68 51 49 88 138
CLONIDINE HCL 67 62* 18 89 55
OXYBUTYNIN CHLORIDE ER 63 49 12 90 156
ESTRADIOL 62 57* 12 R 91 159
ENALAPRIL MALEATE 60 <11 <11 92 70
SPIRIVA 60 49 16 92 57
VENLAFAXINE HCL ER 60 45 11 92 91
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 42 34 95 113
BENAZEPRIL HCL 59 <11 <11 95 60
TERAZOSIN HCL 57 57 14 97 144
CARISOPRODOL 55 <11 <11 R 98 152
KLOR-CON M20 55 42 14 98 56
RISPERIDONE 54 49* 12 A 100 97
ISOSORBIDE DINITRATE 54 <11 <11 100 258
GLIPIZIDE XL 54 <11 <11 100 90
ONGLYZA 54 49* 11 100 193
METFORMIN HCL ER 54 <11 <11 100 40
VYTORIN 53 <11 <11 105 146
NIFEDIPINE ER 53 <11 <11 105 101
GLIMEPIRIDE 52 36 12 107 37
AVELOX 51 32 44 108 369
GLYBURIDE 51 46* 11 R 108 122
PROPRANOLOL HCL 51 <11 <11 108 115
PRAMIPEXOLE DIHYDROCHLORIDE 51 <11 <11 108 177
LANTUS 51 46* 11 108 62
DIGOXIN 50 45* 12 113 239
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.